Last updated: March 6, 2026
What is EQUALINE ALL DAY ALLERGY D?
EQUALINE ALL DAY ALLERGY D is an over-the-counter antihistamine formulated to provide 24-hour relief from allergy symptoms such as sneezing, runny nose, and itchy eyes. The product contains an active ingredient, typically diphenhydramine or chlorpheniramine, combined with other excipients to optimize stability, absorption, and consumer appeal.
What are the key excipients in EQUALINE ALL DAY ALLERGY D?
The formulation includes several excipients that serve specific roles:
- Binders: Microcrystalline cellulose, which provides tablet integrity.
- Disintegrants: Crospovidone, facilitating tablet breakup in GI fluids.
- Diluents: Lactose monohydrate, acting as a filler and ensuring uniformity.
- Dissolution aids: Colloidal silicon dioxide assists in tablet disintegration.
- Lubricants: Magnesium stearate reduces friction during manufacturing.
- Flavoring agents: Orange or cherry flavorings improve consumer acceptance.
- Colorants: FD&C dyes provide visual appeal (e.g., FD&C Red No. 40, Yellow No. 6).
The precise excipient composition depends on proprietary formulation choices, but the strategy involves selecting excipients that maximize stability, bioavailability, and customer satisfaction.
What are the excipient strategy considerations?
Effective excipient strategy for EQUALINE ALL DAY ALLERGY D involves:
Stability and Shelf Life
- Use of microcrystalline cellulose and lactose monohydrate ensures physical stability.
- Incorporation of antioxidants like ascorbyl palmitate prevents excipient and active ingredient degradation.
Dissolution and Absorption
- Crospovidone enhances rapid disintegration, supporting quick onset.
- Disintegrants are optimized for minimal variability in dissolution time.
Manufacturing Efficiency
- Magnesium stearate provides consistent lubrication.
- Use of direct compression-friendly excipients reduces production costs and complexity.
Consumer Acceptance
- Flavoring and coloring increase product appeal.
- Excipients are selected free from allergens (e.g., gluten-free options), aligning with consumer health concerns.
Regulatory Compliance
- All excipients comply with FDA regulations (21 CFR standards).
- Use of GRAS (Generally Recognized As Safe) excipients ensures regulatory approval pathways are streamlined.
Innovation Opportunities
- Development of novel disintegrants or taste-masking agents could differentiate the product.
- Incorporation of moisture locks or controlled-release excipients could extend shelf life or duration of action.
What are the commercial opportunities?
Market and Competition
- The allergy medication segment in OTC drugs exceeds $4 billion annually (IQVIA, 2022).
- Competitive landscape favors products with differentiated excipient profiles enhancing stability and consumer experience.
Product Differentiation
- Formulating allergen-free, gluten-free, or low-sugar excipients can meet niche consumer needs.
- Developing a liquid or chewable format could expand market reach.
Regulatory and Supply Chain
- Sourcing compliant excipients offers a barrier to entry and an opportunity for supply chain differentiation.
- Patent protection on formulation techniques can sustain competitive advantage.
Innovation and R&D
- Leveraging excipients that enable controlled or extended-release formulations can create premium product lines.
- Incorporating technology-driven excipients that boost bioavailability can deliver efficacy advantages.
Regional Opportunities
- Emerging markets exhibit rising OTC allergy treatments; excipient strategies aligned with local regulatory standards can facilitate entry.
How does excipient selection impact market success?
- Stability and shelf life directly influence distribution reach and consumer trust.
- Taste and appearance influence brand loyalty and repeat purchase.
- Manufacturability and cost determine profit margins and pricing strategies.
- Regulatory compliance ensures faster approval timelines and fewer recalls.
Key Takeaways
- Excipient strategy debuts as a critical component in differentiation, stability, and manufacturing in EQUALINE ALL DAY ALLERGY D.
- Choices in excipients impact product efficacy, safety profile, and consumer acceptance.
- Innovations in excipient technology offer opportunities for premium formulations and extended market reach.
- Competitive advantage derives from optimizing excipient formulations to meet regulatory standards and consumer preferences.
- Regional and niche market focus can leverage excipient differentiation to capture emerging opportunities.
FAQs
1. Can changing excipients improve the shelf life of EQUALINE ALL DAY ALLERGY D?
Yes, selecting antioxidants and moisture barriers can extend stability and shelf life.
2. Are allergen-free excipients critical for this product?
Yes, allergen-free excipients align with consumer demand and regulatory standards, broadening market access.
3. How do excipients influence bioavailability in oral allergy medications?
Excipients like disintegrants and dissolution aids impact how quickly and completely the active ingredient dissolves and absorbs.
4. What role do flavoring agents play in excipient strategy?
Flavorings improve consumer compliance and product differentiation, especially in pediatric formulations.
5. How can innovation in excipient technology create new market opportunities?
Novel excipients can support controlled-release systems, improve taste masking, or enhance stability, enabling premium product lines and new delivery forms.
References
[1] IQVIA. (2022). U.S. OTC Pharmaceuticals Market Data.
[2] U.S. Food and Drug Administration. (2023). Title 21, CFR—Food and Drugs.
[3] European Medicines Agency. (2022). Guidelines on Excipient Use and Safety.
